Trees Investment Counsel’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Trees Investment Counsel’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$3.01M	Sell	48,423 -450	-0.9%	-$35.5K	2.66%	16
2015 Q2	$4.11M	Buy	48,873 +699	+1%	+$54.4K	3.27%	5
2015 Q1	$3.62M	Sell	48,174 -525	-1%	-$36.7K	2.93%	12
2014 Q4	$3.03M	Hold	48,699	–	–	2.44%	21
2014 Q3	$2.53M	Hold	48,699	–	–	2.05%	25
2014 Q2	$2.5M	Hold	48,699	–	–	1.96%	27
2014 Q1	$2.31M	Sell	48,699 -1,650	-3%	-$84.5K	1.85%	28
2013 Q4	$2.19M	Sell	50,349 -45,585	-48%	-$1.89M	1.74%	30
2013 Q3	$4.13M	Sell	95,934 -3,561	-4%	-$144K	3.59%	2
2013 Q2	$3.46M	Buy	+99,495	New	+$3.5M	3.17%	5

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Trees Investment Counsel's XBI Position: Q3 2015 in Review

Trees Investment Counsel reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.92% in Q3 2015, selling an estimated $35.5K and leaving 48,423 shares worth $3.01M. The position accounts for 2.66% of the portfolio, ranked #16.

Trees Investment Counsel first reported a position in XBI in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.13M in Q3 2013. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.

Trees Investment Counsel held 48,423 shares of State Street SPDR S&P Biotech ETF worth $3.01M as of Q3 2015.
Trees Investment Counsel sold 450 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $35.5K.
State Street SPDR S&P Biotech ETF made up 2.66% of Trees Investment Counsel's portfolio in Q3 2015, its #16 holding.
Trees Investment Counsel first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 10 quarters since.
Trees Investment Counsel's State Street SPDR S&P Biotech ETF position peaked at $4.13M in Q3 2013.
196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.

Based on Trees Investment Counsel's 13F filing for Q3 2015, filed 16 Oct 2015.